Its actually $1.1m cash burn per Q
$7.2m cash on hand
Less
$1.6m R and D
$200k collected from Limepay B sheet
= $5.4m
6.5 - 5.4
= $1.1m cash-burn per Q (not including R&D)
**Once could argue the R and D added back drops costs and could be seen as $700k cash loss per Q
Speaking of this R and D payment:
I note the R and D expense is never noted in the 4C albeit there is a provision for it
How do they claim and R and D expense when they don't spend money on R and D (not noted) in 4C?
- Forums
- ASX - By Stock
- SPX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-189
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $17.52K | 2.916M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1226984 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 17654222 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1226984 | 0.006 |
51 | 24939523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 17654222 | 29 |
0.008 | 4741717 | 26 |
0.009 | 11710538 | 17 |
0.010 | 846836 | 6 |
0.011 | 527004 | 4 |
Last trade - 14.17pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online